Clinical

Cancer therapies have evolved from conventional cytotoxic chemotherapy to targeted drugs that interfere with specific molecules involved in tumour growth. Targeted drugs that inhibit the epidermal growth factor (EGF) receptor have been successfully tested and are in clinical use for various cancers. Dermatologic toxicity is a unique characteristic of this class of drugs.

Bring on the hot chocolate. A diet rich in cocoa flavanols may help improve vascular function and increase the number of circulating angiogenic cells in heart disease patients, according to a study by researchers at the University of California at San Francisco.